Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001940346 | SCV002195188 | benign | not provided | 2024-08-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001940346 | SCV002526239 | uncertain significance | not provided | 2023-03-03 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (HGMD; Acke et al., 2014); This variant is associated with the following publications: (PMID: 25240749) |
Fulgent Genetics, |
RCV002491900 | SCV002799772 | uncertain significance | Intervertebral disc disorder; Marshall syndrome; Stickler syndrome type 2; Fibrochondrogenesis 1; Hearing loss, autosomal dominant 37 | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538616 | SCV004115670 | uncertain significance | COL11A1-related disorder | 2023-03-08 | criteria provided, single submitter | clinical testing | The COL11A1 c.4709T>C variant is predicted to result in the amino acid substitution p.Leu1570Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.055% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-103352512-A-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |